Assistant Professor UT MD Anderson Cancer Center Houston, Texas
Disclosure(s): No financial relationships to disclose
Disclosure(s):
Jonathan Rowland, MD: No financial relationships to disclose
Are you tired of doctor googling your way through those cancer patients checking into your ER? Are you not sure if alemtuzumab and atezolizumab are different, or if they're even both for cancer? Well, I'm here to tell you there's no way around the absolute necessity of google, but there are a few quick easy-to-remember principles that will make your doctor googling far more efficient and productive. Join me for a very informal talk that will include a brief refresher on standard oncologic emergencies and a review of critical concepts for modern cancer care such as "immunotherapy" (or perhaps better defined as "immune checkpoint inhibitor therapy"), CAR-T, and post-operative complications.
Learning Objectives:
Develop an approach to quickly identify the resources needed to care for their cancer patients in an informed manner.
Identify risk factors for complications such as ICI-related immunotherapy, chimeric antigen receptor T-cell (CAR-T) therapy, and postoperative complications in their patients.
Engage their patients in brief but necessary discussions regarding goals-of-care, specifically to determine code status as quickly as possible, and provide palliative care every step of the way.
